EUVIMEDEUVIMED entdecken
Open Access

Chemokine CCL19 promotes type 2 T-cell differentiation and allergic airway inflammation

Keiko Nakano, Gregory S Whitehead, Miranda R Lyons-Cohen, Sara A Grimm, Christina L Wilkinson, Gentaro Izumi, Alessandra Livraghi-Butrico, Donald N Cook, Hideki Nakano

Journal of Allergy and Clinical Immunology · 2024

DOI: 10.1016/j.jaci.2023.10.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2024. Verfasst von Keiko Nakano und 8 weiteren Autor:innen. Beteiligte Einrichtung: Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle …. Hauptthemen laut MEDLINE: Asthma, Hypersensitivity. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, AHRQ HHS, Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Allergic asthma is driven largely by allergen-specific TH2 cells, which develop in regional lymph nodes on the interaction of naive CD4+ T cells with allergen-bearing dendritic cells that migrate from the lung. This migration event is dependent on CCR7 and its chemokine ligand, CCL21. However, is has been unclear whether the other CCR7 ligand, CCL19, has a role in allergic airway disease. OBJECTIVE: This study sought to define the role of CCL19 in TH2 differentiation and allergic airway disease. METHODS: Ccl19-deficient mice were studied in an animal model of allergic asthma. Dendritic cells or fibroblastic reticular cells from wild-type and Ccl19-deficient mice were cultured with naive CD4+ T cells, and cytokine production was measured by ELISA. Recombinant CCL19 was added to CD4+ T-cell cultures, and gene expression was assessed by RNA-sequencing and quantitative PCR. Transcription factor activation was assessed by flow cytometry. RESULTS: Lungs of Ccl19-deficient mice had less allergic airway inflammation, reduced airway hyperresponsiveness, and less IL-4 and IL-13 production compared with lungs of Ccl19-sufficient animals. Naive CD4+ T cells cocultured with Ccl19-deficient dendritic cells or fibroblastic reticular cells produced lower amounts of type 2 cytokines than did T cells cocultured with their wild-type counterparts. Recombinant CCL19 increased phosphorylation of STAT5 and induced expression of genes associated with TH2 cell and IL-2 signaling pathways. CONCLUSIONS: These results reveal a novel, TH2 cell-inducing function of CCL19 in allergic airway disease and suggest that strategies to block this pathway might help to reduce the incidence or severity of allergic asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaHypersensitivityAnimalsMiceChemokine CCL19Receptors, CCR7LigandsInflammationLungAllergensCell DifferentiationTh2 CellsDendritic Cells

Stichwörter der Autor:innen

AsthmaCCL19IL-2STAT5T(H)2 cellsdendritic cellsfibroblastic reticular cells

Substanzen

Chemokine CCL19Receptors, CCR7LigandsAllergens

Autor:innen und Institutionen

  • Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC.
  • Integrative Bioinformatics Support Group, Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC.
  • Marsico Lung Institute, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC.
  • Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC. Electronic address: cookd@niehs.nih.gov.
  • Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC. Electronic address: nakanoh@niehs.nih.gov.

Förderung

  • NHLBI NIH HHS
  • AHRQ HHS
  • Intramural NIH HHS
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute
  • National Institute of Environmental Health Sciences

Zitieren

APA

Nakano, K., Whitehead, G. S., Lyons-Cohen, M. R., Grimm, S. A., Wilkinson, C. L., Izumi, G., Livraghi-Butrico, A., Cook, D. N., & Nakano, H. (2024). Chemokine CCL19 promotes type 2 T-cell differentiation and allergic airway inflammation. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2023.10.024

Vancouver

Nakano K, Whitehead GS, Lyons-Cohen MR, Grimm SA, Wilkinson CL, Izumi G, et al. Chemokine CCL19 promotes type 2 T-cell differentiation and allergic airway inflammation. Journal of Allergy and Clinical Immunology. 2024. doi:10.1016/j.jaci.2023.10.024

BibTeX
@article{Nakano2024,
  author = {Nakano, Keiko and Whitehead, Gregory S and Lyons-Cohen, Miranda R and Grimm, Sara A and Wilkinson, Christina L and Izumi, Gentaro and Livraghi-Butrico, Alessandra and Cook, Donald N and Nakano, Hideki},
  title = {Chemokine CCL19 promotes type 2 T-cell differentiation and allergic airway inflammation},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2024},
  doi = {10.1016/j.jaci.2023.10.024}
}
Kostenlos starten →